GSK Investigational Site

Gyöngyös 3200

0 studies enrolling now · 3 studies all time

What they study most

Lung Cancer, Non-Small Cell, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
• A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer — Running, not enrolling
• A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD — Completed